Pelvic fracture study aims to settle surgery vs. No-Surgery debate

NCT ID NCT07351123

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at two ways to treat pelvic fractures in people aged 60 and older: surgery or non-surgical care. Researchers will follow 120 patients to see if a larger trial comparing these treatments is possible. The goal is to understand patient and surgeon preferences and whether data can be collected reliably.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could pave the way for a larger trial that determines whether surgery or non-surgical care is better for pelvic fractures in older adults.
What could go wrong
This is a small feasibility study, not a treatment trial. It won't directly answer which treatment is better, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients ≥ 60 years of age with a closed pelvic ring fracture with an anterior and posterior injury observable on x-ray or CT scan.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

The inclusion criteria are: 1. Patient 60 years of age or older. 2. Low energy injury mechanism. 3. LC1 pelvis fracture (AO/OTA 61B1.1,61B2.1, or 61B3.2) confirmed with antero-posterior, inlet, and outlet pelvis radiographs, computed tomography, or magnetic resonance imaging. 4. Fracture displacement of \<10 mm of the posterior pelvic ring on computed tomography of the pelvis. 5. Injury occurred within 21 days of screening. The exclusion criteria are: 1. Patient did not ambulate prior to injury. 2. Severely frail patients (Clinical Frailty Scale ≥7). 3. Patient has another condition, injury, or fracture that prevents post-operative weightbearing on any extremity. 4. Retained implants around the pelvis that precludes or limits either study treatment. 5. Infection around the hip (soft tissue or bone). 6. Pathologic fracture with a lytic lesion in the pelvis or sacrum that precludes internal fixation. 7. Patient is too ill, in the judgement of the attending surgeon, for internal fixation. 8. Patient is too ill, in the judgement of the attending surgeon, for nonoperative care. 9. Problems, in the judgment of study personnel, with maintaining follow-up with the patient. 10. Expected injury survival of less than 12 months. 11. Terminal illness with expected survival of less than 12 months. 12. Currently enrolled in a study that does not permit co-enrollment. 13. Prior enrollment in the study. 14. Unable to obtain informed consent due to language barriers. 15. Unable to obtain informed consent because a legally authorized representative (LAR) was unavailable. 16. Did not provide informed consent (declined participation). 17. Patient or LAR not approached to participate in the trial (missed patient). 18. Other reason to exclude the patient, as approved by the Principal Investigator.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fragility fractures of the pelvis (FFP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Maryland, Baltimore

    RECRUITING

    Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.